MyFinsight
Home
Blog
About
Back
Income Statement
Intellia Therapeutics, Inc. (NTLA)
Intellia Therapeutics, Inc. (NTLA)
source: myfinsight.com
Comprehensive loss
-$107,424K
(-5.67%↓ Y/Y)
Interest income
$5,797K
(-21.68%↓ Y/Y)
Change in fair value of
investments, net
$329K
(-75.43%↓ Y/Y)
Net loss
-$106,634K
(-5.31%↓ Y/Y)
Unrealized (loss) gain on
marketable securities
-$790K
(-95.54%↓ Y/Y)
Total other income,
net
$6,126K
(-29.92%↓ Y/Y)
Operating loss
-$112,760K
(-2.51%↓ Y/Y)
Collaboration revenue
$7,659K
(-46.23%↓ Y/Y)
Total operating
expenses
$120,419K
(-3.08%↓ Y/Y)
Research and development
$82,595K
(-14.88%↓ Y/Y)
General and
administrative
$37,824K
(39.03%↑ Y/Y)
Back